Loading the security overview…
Where the tokens are
| Quarter | Reported | EPS | EPS vs year ago | Revenue | Revenue vs year ago | Consensus EPS |
|---|---|---|---|---|---|---|
| Q2 FY26ended Jun 30, 2026 | Aug 4, 2026 | $2.81 | +37.7% | $1.67B | +37.7% | $1.97 |
| Q1 FY26ended Mar 31, 2026 | May 5, 2026 | $1.47 | +83.7% | $1.27B | +20.9% | $1.38 |
| Q4 FY25ended Dec 31, 2025 | — | $1.46 | +46.0% | $1.51B | +27.8% | — |
| Q3 FY25ended Sep 30, 2025 | — | $2.11 | +290.7% | $1.37B | +20.0% | — |
| Q2 FY25ended Jun 30, 2025 | — | $2.04 | — | $1.22B | +16.5% | — |
| Q1 FY25ended Mar 31, 2025 | — | $0.80 | +6.7% | $1.05B | +19.5% | — |
| Q4 FY24ended Dec 31, 2024 | — | $1.00 | +12.4% | $1.18B | +16.3% | — |
| Q3 FY24ended Sep 30, 2024 | — | $0.54 | −28.9% | $1.14B | +23.8% |
Growth compares each quarter with the same fiscal quarter a year earlier, and is left blank where that quarter is missing or its figure was zero or a loss. Consensus is the estimate published before each report. It usually refers to adjusted EPS, so it is shown beside the GAAP figure rather than subtracted from it: the difference would not be a beat or a miss.
Figures describe Incyte shares, not any token. As of Aug 4, 2026, from Massive's standardised financials and the earnings calendar.
| — |
| Q2 FY24ended Jun 30, 2024 | — | −$2.04 | — | $1.04B | — | — |
| Q1 FY24ended Mar 31, 2024 | — | $0.75 | — | $880.89M | — | — |
| Q4 FY23ended Dec 31, 2023 | — | $0.89 | — | $1.01B | — | — |
| Q3 FY23ended Sep 30, 2023 | — | $0.76 | — | $919.03M | — | — |